Dr. Stergachis’ research and teaching focuses primarily on the safety and use of medicines and vaccines in LMICs. He is Associate Dean for Research and Graduate Programs in the School of Pharmacy, Director of the Global Medicines Program and Director of the Biomedical Regulatory Affairs Program, University of Washington. He also serves as Adjunct Professor of Health Metrics Sciences, Epidemiology and Health Systems & Population Health. He directed a pregnancy registry study on the safety of antimalarials in sub-Saharan African countries. He has developed novel approaches for HIV pharmacovigilance and strengthening pharmacy services in LMICs. He is co-investigator for a study to estimate the global burden of AMR. He has conducted antimicrobial consumption and antimicrobial use projects in Tanzania. A licensed pharmacist, his interests also include antimicrobial stewardship. He is an elected member of the National Academy of Medicine, having served on numerous committees. Previously, he was senior advisor to the Bill & Melinda Gates Foundation Safety Surveillance Working Group, a member of the US FDA Drug Safety and Risk Management Advisory Committee, and Chair of the Malaria in Pregnancy Consortium Safety Working Group. He is a Fellow of the American Pharmacists Association and of the International Society for Pharmacoepidemiology.
Dr. Andy Stergachis
Professor of Pharmacy & Global Health